Birth Injury and Birth Defect Articles
December 15, 2016. By Jane Mundy.
Washington, DC: Studies have shown that some anti-epileptic drugs (AEDs) are safer than others during pregnancy. For instance, Lyrica is classified as Category C while Topamax has Category D status. But both AEDs have been associated with birth defects.Read [ Lyrica and Topamax: Same but Different ]
November 16, 2016. By Jane Mundy.
Osseo, MN:When the FDA approved Lyrica in 2007 to treat fibromyalgia, Pfizer’s profits likely skyrocketed as the disease affects about 3 million to 6 million people in the US each year. It took the agency two more years to warn about possible Lyrica birth defects—how many pregnant women suffering from fibromyalgia took the anticonvulsant drug without knowing?Read [ Who should be Prescribed Lyrica? ]
October 10, 2016. By Jane Mundy.
Washington, DC: Is Lyrica safe? It depends who you ask. Studies indicate the risk of birth defects is high, but Pfizer, the manufacturer, disagrees. And perhaps the benefits outweigh the risks for an epileptic patient. Maybe not so much for women taking the anticonvulsant drug off-label…Read [ Lyrica Birth Defects Cause for Concern ]
September 29, 2016. By Gordon Gibb.
Greenville, NC: Lyrica is part of a class of medications originally approved by the US Food and Drug Administration (FDA) for treatment and management of elliptic seizures, although in recent years indications have expanded to include symptoms of neuropathy and fibromyalgia, an increasingly common complaint. However, a basket of Lyrica side effects – many of them serious – have many patients considering a defective product lawsuit over the alleged harm the drug may be doing to them long term.Read [ Lyrica not Music to Chiropractor’s Ears ]
September 12, 2016. By Jane Mundy.
Houston, TX: Another Zofran lawsuit filed by parents in Texas joins more than 300 suits filed nationwide against the manufacturer. Most all federal cases consolidated into a multidistrict litigation in Massachusetts are making progress and a first trial date is expected soon.Read [ Zofran Litigation Making Progress ]
August 22, 2016. By Jane Mundy.
Washington, DC: Since the anticonvulsant drug Lyrica was developed at Northwestern University, studies indicate that it is associated with birth defects.Read [ Lyrica Studies Indicate Possible Birth Defects ]
August 10, 2016. By Jane Mundy.
Birmingham, AL: Many women who took Zofran during their pregnancy had idea that it is prescribed “off-label”, meaning it wasn’t approved by the FDA to treat morning sickness.Read [ Zofran Complaints Mounting with Increased Awareness of Birth Defects ]
July 7, 2016. By Jane Mundy.
Hattiesburg, MS: “Getting money from the Zofran class-action lawsuit isn’t as important to me as getting the word out to the public about how dangerous this drug is,” says Lucy. Her daughter was born with clubfoot, a birth defect associated with Zofran.Read [ Mothers Regret Taking Zofran ]
June 15, 2016. By Jane Mundy.
Pittsburgh, PA: While Zofran birth defects lawsuits continue to be filed, a recent study has not found a link between the anti-nausea drug and birth defects.Read [ Zofran Studies: Link or No Link to Birth Defects? ]
May 30, 2016. By Heidi Turner.
Los Angeles, CA: A new study conducted by researchers at UCLA suggests there is no link between Zofran and birth defects. The study comes as more women are filing lawsuits alleging their infants suffered serious Zofran side effects after exposure in the womb. It also contradicts previous research that suggested a link between the anti-nausea medication and birth defects. Among the side effects alleged in the Zofran lawsuits are an increased risk of heart defects and cleft palate.Read [ New Study Suggests No Link between Zofran and Birth Defects ]